w 12 has been researched along with Bowel Diseases, Inflammatory in 1 studies
W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring
| Excerpt | Relevance | Reference |
|---|---|---|
| " Model-informed precision dosing [MIPD; i." | 1.91 | A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases. ( Dreesen, E; Ferrante, M; Hoffman, I; Kantasiripitak, W; Thomas, D; van Hoeve, K; Vermeire, S; Wicha, SG, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantasiripitak, W | 1 |
| Wicha, SG | 1 |
| Thomas, D | 1 |
| Hoffman, I | 1 |
| Ferrante, M | 1 |
| Vermeire, S | 1 |
| van Hoeve, K | 1 |
| Dreesen, E | 1 |
1 other study available for w 12 and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
Topics: Child; Drug Monitoring; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Re | 2023 |